ALNY Financials

Alnylam Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$333.39

Market Cap

$45.01B

P/E Ratio

145.0

EPS

$2.34

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$2.25B

Gross Profit

Operating Income

Net Income

$-278.16M

EPS (Diluted)

$-2.18

Balance Sheet Highlights

Total Assets

$4.24B

Total Liabilities

$4.17B

Shareholders Equity

Cash & Equivalents

$966.43M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-8.31M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

81.6%

Operating Margin

0.1%

Net Margin

0.1%

ROE

0.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ALNY revenue?

ALNY's most recent quarterly revenue was $2.25B. Annual revenue can be calculated by summing the four most recent quarters.

Is ALNY profitable?

ALNY reported a loss of $278.16M in the most recent quarter. The net profit margin is 0.1%.

What is ALNY market cap?

ALNY has a market capitalization of $45.01B, making it a large-cap stock.

Does ALNY have debt?

View ALNY's balance sheet for debt information.

What is ALNY cash flow?

Cash flow data is available in the full financial statements.